Date
Sponsor content
2 result(s) found, displaying 1 to 2
-
Dec-2025Prescription medicine evaluationActive ingredient: SARS-CoV-2 LP.8.1 mRNA.
-
Jun-2025Prescription medicine evaluationActive ingredient: respiratory syncytial virus F protein mRNA (nucleoside modified).